Journal de la Faculté de Médecine
Volume 4, Numéro 1, Pages 527-532
2020-06-21
Authors : Nachi Mourad . Kihek Ibtissem . Entasoltan Badra . Taibi Karima . Guella Mohamed Djaoued . Abed Amine . Boukhatmi Yasmine . Bekadja Mohamed Amine .
Aim. In chronic myeloid leukemia (CML), the research of BCR-ABL1 fusion transcript became essential to confirm the molecular diagnosis. In this study, we describe the different types of BCR-ABL1 fusion transcripts found in CML patients in West Algerian patients. Methods. A total of 167 CML suspected patients were included in our study. A qualitative research on fusion transcripts was carried out by reverse transcription polymerase chain reaction (RT-PCR) technique in the biochemistry laboratory of Oran’s university hospital establishment. Results. The two types of major BCR-ABL1 fusion transcript Mb3a2 and Mb2a2 were present in 59,8 % and 36,4% of cases respectively. Two patients (1,8%) had an atypical and rare transcript type e19a2 and two others (1,8%) co-expressed b3a2 and b2a2 transcript types. Conclusion. Our study confirmed the data in the literature with a higher incidence of the major transcript.
Chronic Myeloid Leukemia, multiplex RT-PCR, BCR-ABL1 Transcript, rare fusion transcripts, Co-expression b3a2/b2a2
Cherif Hosni Aicha
.
Kehal Samia
.
Meghrebi Sara
.
Lahmer Imene
.
Messaoudi Reda
.
pages 452-459.
Bouzenda Khaled
.
Mahdjoub Esma
.
Lemrabet Amina
.
Rouabeh Hadjer Zineb
.
pages 6-12.
Khellaf Ghalia
.
Koceir El Hadj Ahmed
.
Benabadji Mohamed
.
pages 507-512.
Baudin Bruno
.
Isnard Françoise
.
Mailloux Agnès
.
Zunic Patricia
.
Tahraoui Abdelkrim
.
Bénéteau-burnat Bénédicte
.
Garderet Laurent
.
Vaubourdolle Michel
.
pages 24-32.
Barkati I
.
Messaoudi A
.
Rayane T
.
Benyagoub M
.
pages 145-151.